| Name | Title | Contact Details |
|---|
Medterra takes pride in providing our customers with the highest quality pure CBD, grown and processed in the USA.
Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1988, Health Design Plus (HDP) initially a Care Management company, expanded its suite of services to include network development/management and claims administration. With over 25 years of continued success, Health Design Plus continues to offer new products, such as Good Health by Design®, a suite of Wellness programs including LifeStart®, a Maternity Management program, Wellness Counts®, a biometric screening and coaching program, Carewise®, a Care Management program, and Healthy Living™, a Disease Management program, designed to fit all wellness-readiness levels, promoting healthier lifestyle choices and behavior modification to reach personal goals. Health Design Plus helps clients fuel their fiscal health in the marketplace while improving the health of their employees and members. Recently, HDP has gained national recognition as the industry leader in Domestic Travel Surgery programs with the launch of CliniFIT™ Centers of Excellence. HDP`s CliniFIT™ Centers of Excellence programs offer employers unparalleled commitment to consistently deliver safe, effective, evidence-based care. Qualified employees have access to recognized leaders in specific fields of medicine, Cardiac, Spine and Joint Replacement.
Life Plus is a Batesville, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.